专利检索 ap:("Epics Therapeutics") AND inv:"Didier Schils" 第 1 页

1.

发明授权
Substituted pyrrolidines as G-protein coupled receptor 43 agonists 有权

公开(公告)号：US11072582B2

公开(公告)日：2021-07-27

申请号：US16929573

申请日：2020-07-15

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07D295/10 , C07D207/16 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/10 , C07D403/14 , C07D405/10 , C07D407/06 , C07D409/10 , C07D413/10 , C07D413/12

摘要： The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

2.

发明申请
SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS 审中-公开

公开(公告)号：US20200347016A1

公开(公告)日：2020-11-05

申请号：US16929573

申请日：2020-07-15

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07D207/16 , C07D277/06 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/10 , C07D403/14 , C07D405/10 , C07D407/06 , C07D409/10 , C07D413/10 , C07D413/12

摘要： The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

3.

发明申请
SUBSTITUTED PYRROLIDINES AS G-PROTEIN COUPLED RECEPTOR 43 AGONISTS 审中-公开

公开(公告)号：US20190300478A1

公开(公告)日：2019-10-03

申请号：US16444781

申请日：2019-06-18

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07D207/16 , C07D413/12 , C07D413/10 , C07D409/10 , C07D407/06 , C07D405/10 , C07D277/06 , C07D403/10 , C07D401/12 , C07D401/06 , C07D401/04 , C07D403/14

摘要： The present invention is directed to novel compounds of formula (I) and their use in treating and or preventing metabolic diseases.

4.

发明授权
Substituted pyrrolidines as G-protein coupled receptor 43 agonists 有权

公开(公告)号：US10781171B2

公开(公告)日：2020-09-22

申请号：US16745727

申请日：2020-01-17

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07C63/06 , C07C63/10 , C07D213/78 , C07D213/80 , C07D207/16 , C07D413/12 , C07D413/10 , C07D409/10 , C07D407/06 , C07D277/06 , C07D403/14 , C07D403/10 , C07D401/12 , C07D401/06 , C07D401/04 , C07D405/10

摘要： The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

5.

发明申请
PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERS AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 43 (GPR43) 审中-公开

公开(公告)号：US20200148636A1

公开(公告)日：2020-05-14

申请号：US16745727

申请日：2020-01-17

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07D207/16 , C07D413/12 , C07D413/10 , C07D409/10 , C07D407/06 , C07D405/10 , C07D403/14 , C07D403/10 , C07D401/12 , C07D401/06 , C07D401/04 , C07D277/06

摘要： The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

6.

发明授权
Substituted pyrrolidines as G-protein coupled receptor 43 agonists 有权

公开(公告)号：US10577318B2

公开(公告)日：2020-03-03

申请号：US16444781

申请日：2019-06-18

申请人： Epics Therapeutics

发明人： Hamid R. Hoveyda , Didier Schils , Ludivine Zoute , Julien Parcq

IPC分类号： C07D295/10 , C07D207/16 , C07D413/12 , C07D413/10 , C07D409/10 , C07D407/06 , C07D403/14 , C07D277/06 , C07D403/10 , C07D401/12 , C07D401/06 , C07D401/04 , C07D405/10

摘要： The present invention is directed to novel intermediates of the formula E: which are useful in the synthesis of agonists of g-protein coupled receptor 43 for treating and/or preventing metabolic diseases.